VMI

VHCP Management III Portfolio holdings

AUM $504M
1-Year Est. Return 683.12%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+683.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$504M
AUM Growth
+$342M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
26
New
Increased
Reduced
Closed

Top Buys

1
+$70.7M
2
+$26.7M
3
+$23.3M
4
ADVM
Adverum Biotechnologies
ADVM
+$8.34M
5
FTSV
Forty Seven, Inc. Common Stock
FTSV
+$8.29M

Top Sells

1
+$15.9M
2
+$11M
3
+$9.85M
4
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$7.76M
5
AXSM icon
Axsome Therapeutics
AXSM
+$2.56M

Sector Composition

1 Healthcare 97.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXSM icon
1
Axsome Therapeutics
AXSM
$8.24B
$160M 31.77%
1,547,994
-63,335
CNST
2
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$119M 23.54%
2,516,242
+2,449,575
MIST icon
3
Milestone Pharmaceuticals
MIST
$152M
$33.1M 6.57%
2,066,529
RLMD icon
4
Relmada Therapeutics
RLMD
$473M
$29.9M 5.95%
+767,938
ETNB
5
DELISTED
89bio
ETNB
$25.2M 5%
+958,765
TXG icon
6
10x Genomics
TXG
$2.31B
$22.9M 4.54%
300,000
FTSV
7
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$20.3M 4.04%
+516,381
ITCI
8
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$19.7M 3.92%
+575,000
ISEE
9
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$14.6M 2.9%
+1,699,797
KALV icon
10
KalVista Pharmaceuticals
KALV
$837M
$11M 2.19%
619,905
-17,979
ADVM
11
DELISTED
Adverum Biotechnologies
ADVM
$10.9M 2.16%
+94,623
MRNS
12
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$10.8M 2.15%
1,254,041
+625,000
MRSN
13
DELISTED
Mersana Therapeutics
MRSN
$8.95M 1.78%
+62,456
MYOV
14
DELISTED
Myovant Sciences Ltd.
MYOV
$7.07M 1.4%
+455,255
NXTC icon
15
NextCure
NXTC
$43.2M
$6.74M 1.34%
+9,974
OBSV
16
DELISTED
ObsEva SA Ordinary Shares
OBSV
$3.1M 0.61%
810,264
-349,525
PTGX icon
17
Protagonist Therapeutics
PTGX
$6.2B
$571K 0.11%
80,929
-991,419
BLPH
18
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$134K 0.03%
25,597
-135,551
BCRX icon
19
BioCryst Pharmaceuticals
BCRX
$2.31B
– –
-2,708,207
KNSA icon
20
Kiniksa Pharmaceuticals
KNSA
$3.6B
– –
-277,137
KA
21
DELISTED
Kineta, Inc. Common Stock
KA
– –
-1,580
PRVL
22
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
– –
-4,408
RARX
23
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-670,350
LJPC
24
DELISTED
La Jolla Pharmaceutical Company
LJPC
– –
-1,251,898
TCDA
25
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-80,348
1
2